Zimmer Biomet Holdings
Stock Forecast, Prediction & Price Target
Zimmer Biomet Holdings (ZBH) stock Price Target by analysts
Zimmer Biomet Holdings (ZBH) stock Price Target by analysts
Average Price Target
$119.17
Potential upside: 14.24%
Zimmer Biomet Holdings price prediction
What is Zimmer Biomet Holdings stock analysts` prediction?
Zimmer Biomet Holdings stock forecast: Based on 5 Wall Street analysts` predicted price targets for Zimmer Biomet Holdings in the last 3 months, the avarage price target is $119.17, with a high forecast of $NaN. The average price target represents a 14.24% change from the last price of $104.31.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Zimmer Biomet Holdings stock Price Target by analysts
Full breakdown of analysts given Zimmer Biomet Holdings price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Richard Newitter Truist Financial | 0% 0/2 | 10 months ago | $117 12.16% upside | $106.92 | StreetInsider | Previous targets (1) |
Steven Lichtman Oppenheimer | 0% 0/3 | 11 months ago | $135 29.42% upside | $104.83 | StreetInsider | Previous targets (2) |
Ryan Zimmerman BTIG | 0% 0/2 | 11 months ago | $126 20.79% upside | $105.69 | TheFly | Previous targets (1) |
Vijay Kumar Evercore ISI | 0% 0/2 | 11 months ago | $110 5.45% upside | $107.95 | TheFly | Previous targets (1) |
Richard Newitter Truist Financial | 0% 0/2 | 12 months ago | $112 7.37% upside | $105.14 | TheFly | Previous targets (1) |
Caitlin Cronin Canaccord Genuity | 0% 0/1 | 12 months ago | $115 10.24% upside | $104.83 | TheFly | Previous targets (0) |
Jayson Bedford Raymond James | 0% 0/1 | about 1 year ago | $128 22.71% upside | $107.09 | TheFly | Previous targets (0) |
Steven Lichtman Oppenheimer | 0% 0/3 | about 1 year ago | $145 39.00% upside | $105.81 | TheFly | Previous targets (2) |
Rick Wise Stifel Nicolaus | 0% 0/1 | about 1 year ago | $130 24.62% upside | $107.5 | TheFly | Previous targets (0) |
Drew Ranieri Morgan Stanley | 0% 0/1 | about 1 year ago | $120 15.04% upside | $108.69 | TheFly | Previous targets (0) |
Matt O'Brien Piper Sandler | 50% 1/2 | about 1 year ago | $115 10.24% upside | $108.53 | TheFly | Previous targets (1) |
Matthew O'Brien Piper Sandler | 50% 1/2 | over 1 year ago | $140 34.21% upside | $114.44 | StreetInsider | Previous targets (1) |
Shagun Singh RBC Capital | 0% 0/1 | over 1 year ago | $140 34.21% upside | $115.14 | StreetInsider | Previous targets (0) |
Ryan Zimmerman BTIG | 0% 0/2 | over 1 year ago | $139 33.25% upside | $116.41 | StreetInsider | Previous targets (1) |
David Toung Argus Research | 0% 0/1 | over 1 year ago | $150 43.80% upside | $119.05 | StreetInsider | Previous targets (0) |
Zimmer Biomet UBS | 100% 1/1 | almost 2 years ago | $125 19.83% upside | $120.65 | Defense World | Previous targets (0) |
Zimmer Biomet Stifel Nicolaus | 0% 0/1 | almost 2 years ago | $165 58.18% upside | $120.65 | Defense World | Previous targets (0) |
Zimmer Biomet Truist Financial | 0% 0/1 | almost 2 years ago | $148 41.88% upside | $120.65 | Defense World | Previous targets (0) |
Zimmer Biomet BTIG | 0% 0/1 | almost 2 years ago | $139 33.25% upside | $120.65 | Defense World | Previous targets (0) |
Unknown Truist Financial | N/A | over 2 years ago | $137 31.33% upside | $128.46 | Benzinga | N/A |
Unknown Morgan Stanley | N/A | over 2 years ago | $140 34.21% upside | $128.83 | Benzinga | N/A |
Unknown RBC Capital | N/A | over 2 years ago | $141 35.17% upside | $125.7 | Benzinga | N/A |
Unknown Morgan Stanley | N/A | over 2 years ago | $135 29.42% upside | $126.77 | Benzinga | N/A |
Unknown Truist Financial | N/A | over 2 years ago | $135 29.42% upside | $124.91 | Benzinga | N/A |
Unknown Citigroup | N/A | over 2 years ago | $130 24.62% upside | $125.36 | Benzinga | N/A |
Larry Biegelsen Wells Fargo | 100% 1/1 | almost 3 years ago | $124 18.87% upside | $115.33 | TheFly | Previous targets (0) |
Unknown Stifel Nicolaus | N/A | about 3 years ago | $120 15.04% upside | $104.62 | Benzinga | N/A |
Unknown RBC Capital | N/A | over 3 years ago | $128 22.71% upside | $122.2 | Benzinga | N/A |
Matt O'Brien Piper Sandler | 50% 1/2 | over 3 years ago | $130 24.62% upside | $121.37 | TheFly | Previous targets (1) |
Travis Steed Bank of America Securities | 100% 1/1 | over 3 years ago | $120 15.04% upside | $122.13 | Pulse 2.0 | Previous targets (0) |
Samuel Brodovsky Truist Financial | 100% 1/1 | over 3 years ago | $128 22.71% upside | $116.08 | TheFly | Previous targets (0) |
Shagun Singh Chadha RBC Capital | 100% 1/1 | over 3 years ago | $125 19.83% upside | $116.08 | TheFly | Previous targets (0) |
David Turkaly JMP Securities | 0% 0/1 | over 3 years ago | $145 39.00% upside | $116.08 | TipRanks Contributor | Previous targets (0) |
Kyle Rose Canaccord Genuity | 100% 1/1 | over 3 years ago | $125 19.83% upside | $108.13 | TheFly | Previous targets (0) |
Pito Chickering Deutsche Bank | 100% 1/1 | over 3 years ago | $121 16.00% upside | $108.13 | TheFly | Previous targets (0) |
Michael Matson Needham | 100% 1/1 | over 3 years ago | $143 37.09% upside | $108.13 | TipRanks Contributor | Previous targets (0) |
Danielle Antalffy Leerink Partners | 100% 1/1 | over 3 years ago | $135 29.42% upside | $108.13 | TipRanks Contributor | Previous targets (0) |
Jeff Johnson Robert W. Baird | 100% 1/1 | over 3 years ago | $138 32.29% upside | $108.13 | TheFly | Previous targets (0) |
Matthew O'Brien Piper Sandler | 50% 1/2 | over 3 years ago | $110 5.45% upside | $108.13 | TheFly | Previous targets (1) |
Josh Jennings Cowen & Co. | 100% 1/1 | over 3 years ago | $140 34.21% upside | $119.14 | StreetInsider | Previous targets (0) |
Anders Bylund Motley Fool | 100% 1/1 | over 3 years ago | $140 34.21% upside | $121.23 | TheFly | Previous targets (0) |
Anthony Petrone Jefferies | 0% 0/1 | almost 4 years ago | $175 67.76% upside | $136.9 | StreetInsider | Previous targets (0) |
Christopher Pasquale Guggenheim | 0% 0/1 | almost 4 years ago | $180 72.56% upside | $136.9 | StreetInsider | Previous targets (0) |
Vijay Kumar Evercore ISI | 0% 0/2 | almost 4 years ago | $170 62.97% upside | $133.13 | StreetInsider | Previous targets (1) |
Steven Lichtman Oppenheimer | 0% 0/3 | about 4 years ago | $190 82.14% upside | $143.03 | TheFly | Previous targets (2) |
Zimmer Biomet Holdings Financial Estimates
Zimmer Biomet Holdings Revenue Estimates
Zimmer Biomet Holdings EBITDA Estimates
Zimmer Biomet Holdings Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $6.82B N/A | $6.93B 1.64% | $7.39B 6.54% | Avg: $8.11B Low: $8.06B High: $8.17B avg. 9.79% | Avg: $8.45B Low: $8.37B High: $8.51B avg. 4.19% | Avg: $8.99B Low: $8.90B High: $9.04B avg. 6.29% | Avg: $9.33B Low: $9.25B High: $9.39B avg. 3.86% |
Net Income
% change YoY
| $401.6M N/A | $231.4M -42.38% | $1.02B 342.52% | Avg: $1.19B Low: $891.22M High: $1.40B avg. 17.04% | Avg: $1.34B Low: $1.25B High: $1.53B avg. 11.86% | Avg: $2.12B Low: $2.10B High: $2.14B avg. 58.85% | Avg: $2.23B Low: $2.21B High: $2.25B avg. 5.05% |
EBITDA
% change YoY
| $1.95B N/A | $1.99B 1.80% | $2.21B 11.24% | Avg: $2.31B Low: $2.29B High: $2.32B avg. 4.41% | Avg: $2.40B Low: $2.38B High: $2.42B avg. 4.19% | Avg: $2.56B Low: $2.53B High: $2.57B avg. 6.29% | Avg: $2.65B Low: $2.63B High: $2.67B avg. 3.86% |
EPS
% change YoY
| $1.93 N/A | $1.39 -27.97% | $4.91 253.23% | Avg: $5.66 Low: $4.25 High: $6.68 avg. 15.29% | Avg: $6.54 Low: $5.99 High: $7.32 avg. 15.55% | Avg: $10.16 Low: $10.03 High: $10.24 avg. 55.26% | Avg: $10.67 Low: $10.54 High: $10.76 avg. 5.05% |
Operating Expenses
% change YoY
| $3.86B N/A | $3.72B -3.44% | $4.03B 8.16% | Avg: $3.35B Low: $3.33B High: $3.38B avg. -16.78% | Avg: $3.49B Low: $3.46B High: $3.51B avg. 4.19% | Avg: $3.71B Low: $3.68B High: $3.74B avg. 6.29% | Avg: $3.86B Low: $3.82B High: $3.88B avg. 3.86% |
FAQ
What is Zimmer Biomet Holdings stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 23.20% in 2025-2028.
We have gathered data from 16 analysts. Their low estimate is 891.22M, average is 1.19B and high is 1.40B.
What is Zimmer Biomet Holdings stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 6.03% in 2025-2028.
We have gathered data from 21 analysts. Their low revenue estimate is $8.06B, average is $8.11B and high is $8.17B.
What is Zimmer Biomet Holdings stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 22.79% in 2025-2028.
We have gathered data from 16 analysts. Their low earnings per share estimate is $4.25, average is $5.66 and high is $6.68.
What is the best performing analyst?
In the last twelve months 5 analysts have been covering Zimmer Biomet Holdings stock. The most successful analyst is Richard Newitter.